Sherman Oaks, CA, United States of America

Laith Q Al-Mawsawi

This inventor holds 1 USPTO granted patent. Top assignee: Bioniz, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laith Q Al-Mawsawi. Retrieved from https://idiyas.com/inventor/laith-q-al-mawsawi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laith Q Al-Mawsawi: Innovator in Cytokine Research

Introduction

Laith Q Al-Mawsawi is a prominent inventor based in Sherman Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of cytokine research. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Laith holds a patent titled "Peptides Inhibiting Gamma-c-Cytokine Activity and Methods of Use." This patent represents a breakthrough in understanding and potentially treating conditions related to gamma-c-cytokines. His work in this area showcases his commitment to advancing medical science.

Career Highlights

Laith is currently associated with Bioniz, LLC, where he continues to push the boundaries of research and innovation. His role at the company allows him to collaborate with other talented professionals in the field.

Collaborations

Laith has worked alongside notable colleagues such as Nicholas Doerr and Nazli Azimi. Their combined expertise fosters a dynamic environment for innovation and discovery.

Conclusion

Laith Q Al-Mawsawi is a dedicated inventor whose work in cytokine research is paving the way for new therapeutic approaches. His contributions to the field are invaluable and reflect his passion for improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…